INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 120 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $984,553 | -90.2% | 18,901 | -88.1% | 0.00% | -100.0% |
| Q2 2023 | $10,052,113 | +72.5% | 158,751 | +47.5% | 0.00% | +50.0% |
| Q1 2023 | $5,828,652 | +51.4% | 107,639 | +48.0% | 0.00% | 0.0% |
| Q4 2022 | $3,848,660 | -12.5% | 72,726 | -23.0% | 0.00% | 0.0% |
| Q3 2022 | $4,396,000 | +187.9% | 94,480 | +253.2% | 0.00% | +100.0% |
| Q2 2022 | $1,527,000 | -82.4% | 26,751 | -81.1% | 0.00% | -66.7% |
| Q1 2022 | $8,661,000 | -18.1% | 141,550 | -29.9% | 0.00% | -25.0% |
| Q4 2021 | $10,571,000 | +273.4% | 201,965 | +166.0% | 0.00% | +300.0% |
| Q3 2021 | $2,831,000 | +17.7% | 75,933 | +28.8% | 0.00% | 0.0% |
| Q2 2021 | $2,406,000 | +90.0% | 58,957 | +58.1% | 0.00% | – |
| Q1 2021 | $1,266,000 | -73.8% | 37,290 | -75.5% | 0.00% | -100.0% |
| Q4 2020 | $4,839,000 | -24.6% | 152,153 | -39.1% | 0.00% | -50.0% |
| Q3 2020 | $6,414,000 | -65.1% | 249,957 | -65.1% | 0.00% | -69.2% |
| Q2 2020 | $18,399,000 | +2578.2% | 716,731 | +1503.0% | 0.01% | – |
| Q1 2020 | $687,000 | -93.9% | 44,711 | -86.5% | 0.00% | -100.0% |
| Q4 2019 | $11,323,000 | +1703.0% | 330,025 | +729.6% | 0.02% | +700.0% |
| Q3 2017 | $628,000 | -35.6% | 39,780 | -33.7% | 0.00% | -60.0% |
| Q1 2017 | $975,000 | +418.6% | 59,976 | +381.1% | 0.01% | +400.0% |
| Q4 2016 | $188,000 | -68.5% | 12,467 | -68.1% | 0.00% | -66.7% |
| Q3 2016 | $596,000 | +124.1% | 39,100 | +690.5% | 0.00% | +50.0% |
| Q4 2015 | $266,000 | -62.3% | 4,946 | -71.9% | 0.00% | -50.0% |
| Q3 2015 | $705,000 | +281.1% | 17,617 | +60.2% | 0.00% | +100.0% |
| Q2 2014 | $185,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 359,000 | $18,790,000 | 7.62% |
| Velan Capital Investment Management LP | 150,000 | $7,851,000 | 6.09% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 195,000 | $10,206,000 | 4.14% |
| Vantage Consulting Group Inc | 226,670 | $11,864,000 | 3.19% |
| Vahanian & Associates Financial Planning Inc. | 71,742 | $3,755,000 | 3.03% |
| Nicholas Investment Partners, LP | 652,886 | $34,172,000 | 2.16% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $3,199,000 | 1.97% |
| Bellevue Group AG | 3,628,919 | $189,938,000 | 1.96% |
| WASATCH ADVISORS LP | 8,235,171 | $431,029,000 | 1.76% |
| Quantum Private Wealth, LLC | 77,622 | $4,062,000 | 1.54% |